Shingles and pneumonia and risk of cutaneous basal and squamous cell carcinoma - 08/07/21
Doi : 10.1016/j.jaad.2018.07.049
Aaron M. Drucker, MD, ScM a, b, c, Wen-Qing Li, PhD a, d, Eunyoung Cho, ScD a, d, e, Tricia Li, MSc e, Richard Besdine, MD f, Abrar A. Qureshi, MD, MPH a, b, d, e, ⁎ 
, Eleni Linos, MD, MPH, DrPH g
, Eleni Linos, MD, MPH, DrPH g a Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island
b Department of Dermatology, Rhode Island Hospital, Providence, Rhode Island
c Division of Dermatology, Department of Medicine, Women's College Hospital and University of Toronto and Women's College Research Institute, Toronto, Ontario, Canada
d Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island
f Center for Gerontology and Health Care Research, School of Public Health, Brown University, Providence, Rhode Island
e Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
g Program in Clinical Research, Department of Dermatology, University of California San Francisco, San Francisco, California
∗Correspondence to: Abrar A. Qureshi, MD, MPH, Rhode Island Hospital, 593 Eddy St, APC-10, Providence, RI 02903Rhode Island Hospital593 Eddy St, APC-10ProvidenceRI02903
| Funding sources: Supported in part by the Department of Dermatology of Brown University. Dr Drucker received SURDNA fellowship funding for this project from the Center for Gerontology and Health Care Research, School of Public Health, Brown University. Dr Li is supported by the Richard B. Salomon Faculty Research Award from Brown University and a Research Career Development Award from the Dermatology Foundation. Dr Linos is supported by a National Institute on Aging Beeson grant (K76AG054631) and a University of California San Francisco Pepper Center grant (NIH P30AG044281). The work was supported by a National Institutes of Health grant for the Nurses' Health Study (UM1 CA186107 and P01 CA87969), and the Health Professionals Follow-up Study (UM1 CA167552). |
|
| Disclosure: Dr Drucker served as an investigator for and has received research funding from Sanofi and Regeneron and has been a consultant for Sanofi and RTI Health Solutions; he has received honoraria from Astellas Canada, Prime Inc, Spire Learning, and the Eczema Society of Canada. Dr Qureshi has received honoraria (that have been donated to charity) from Abbvie, Amgen, Centers for Disease Control, Janssen, Merck, Novartis, Pfizer (as a consultant), and Amgen (as an investigator), and he is an investigator for Sanofi and Regeneron. Dr Li, Dr Cho, Ms Li, Dr Besdine, MD, and Dr Linos have no conflicts of interest to disclose. |
|
| The funding sources had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. |
|
| Reprints not available from the authors. |
© 2021
Publié par Elsevier Masson SAS.
Vol 85 - N° 2
P. 492-495 - août 2021 Retour au numéro
Article précédent
- Measurement of skin adhesion in recessive dystrophic epidermolysis bullosa patients
- Jaron Nazaroff, Martin Manoukian, Melissa Barriga, Alfred Lane, M. Peter Marinkovich, Jean Y. Tang
- International Classification of Diseases–based analysis is inaccurate in assessing the prevalence of inflammatory bowel disease in patients with hidradenitis suppurativa
- Daniel A. Gold, Cynthia Nicholson, Gordon Jacobsen, Iltefat H. Hamzavi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?